Company intelligence / Profile preview

Osteogenics Biomedical

Lubbock, Texas, United States

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Osteogenics Biomedical’s products are widely used in clinical practice for dental bone and tissue regeneration. Their portfolio includes FDA-cleared and CE-marked devices such as dPTFE membranes and various xenograft/allograft/synthetic materials. Clinical literature supports their use in procedures like socket preservation and vertical/horizontal ridge augmentation.

Therapeutic areas: OtherDermatology
Modalities: DeviceBiologicSynthetic material
Industry: Surgical Medical Devices

Partnerships

Exclusive distribution rights for NovaBone Dental products in the US/Canadapart of Envista Holdings’ network since acquisition

Beyond the preview

Go deeper on Osteogenics Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteogenics Biomedical.

Explore the full profile